10 results
Approach to Nausea / Vomiting - Differential Diagnosis Framework
 • Gastrointestinal 
    -
Approach to Nausea ... / Vomiting - Differential ... - Vestibular Disorders ... AnthonyXuMD #Nausea #Vomiting ... Differential #Diagnosis #Classification
Blood Disorders - Markers and Differential Diagnosis Algorithm 
Acute
 • Myloid (AML) - CD13, CD33, CD34,
Differential Diagnosis Algorithm ... Lymphadenopathy, CNS ... o CML - bcr-able ... o Other bcr-able ... Differential #Diagnosis #Algorithm
Approach to Elevated Bicarbonate (HCO3)
Risk Factors for Hypercapnea? (Hx of COPD, OSA, sedative use, CNS/muscular disorders?)
(+)
Approach to Elevated ... sedative use, CNS ... /muscular disorders ... Hydrogen loss (Vomiting ... metabolic #alkalosis #algorithm
Overall Approach to Anemia - Differential Diagnosis Algorithm

Blood Loss
 • Acute Bleed - Normocytic / Normochromic
Overall Approach ... Differential Diagnosis Algorithm ... • RBC Membrane Disorder ... Non-lmmune #Anemia #Classification ... #Diagnosis #Algorithm
Chest Pain / ACS Evaluation Algorithm
Algorithm that attempts to the use history taking (guided by LRs),
ACS Evaluation Algorithm ... Algorithm that ... Diamond-Forrester classification ... score to guide an approach ... activity - Nausea/vomiting
ED Opioid Stewardship Algorithm

Opioid Naive vs Opioid Tolerant

1. Patient Specific, Pain Syndrome-Targeted Approach
2. Combinations of Non-Pharmacologic
Opioid Stewardship Algorithm ... Opioid Naive vs ... Syndrome-Targeted Approach ... with Opioid Use Disorder ... #Stewardship #Algorithm
Cyclic Vomiting Syndrome (CVS) - Management Algorithm
General Approach:
 - Identify and avoid triggers
 - Good sleep
Cyclic Vomiting ... Syndrome (CVS) - ... Management Algorithm ... General Approach ... Comorbidities (psychiatric disorders
Inpatient Management of Opioid Use Disorder: Methadone vs Buprenorphine - Comparison Table

Some patients may decline buprenorphine
of Opioid Use Disorder ... : Methadone vs Buprenorphine ... - Comparison Table ... effects are nausea, vomiting
Opioid Use Disorder Medications - Pharmacokinetics

Buprenorphine is a partial mu-opioid receptor agonist with low intrinsic activity,
Opioid Use Disorder ... opioids for 10 days, limiting ... with additional CNS ... the sublingual tablet ... Pharmacokinetics #Comparison #Table
Medications for the Treatment of Hyperkalemia
The goals of acute treatment are to prevent potentially life-threatening cardiac
uncommon, a cautious approach ... the underlying disorder ... Figure 3 is an algorithm ... hyperkalemia, and Table